We are happy to share a strong set of results for FY 2021-22 and alsoinform you that our expansion to manufacture ~10000 MT of camphor is now complete. Weachieved above despite an uncertain and challenging business environment through the Deltaand Omicron waves of COVID-19.
Our net sales stood at Rs 491 Cr during the financial year whichincidentally is also our highest ever revenue compared to Rs 338.26 Cr recorded in theprevious year of FY 20-21 which is a growth of roughly ~45% largely on account of theincreased sales price of camphor and more manufacturing days as compared to the previousperiod.
Our Profit After Tax (PAT) stood at Rs 54 Cr which was ~36% lowerlower during the year vis-a-vis Rs 84.72Cr in the previous year. The reduction is largelyon account of increased cost of raw materials & escalating fuel and power expenses.
A major development has been the successful completion of our delayed(COVID-19) expansion project to be able to manufacture ~10000 MT of camphor. This newfacility now enables us the flexibility to manufacture a number of intermediate productsand take advantage of the demand-supply-pricing situations and maximise our utilisationsand margins. Through all our efforts particularly the burgeoning retail foray we willtry our best to utilise these enhanced capacities in the shortest time possible.
Our Segmental Performance
Camphor is the primary product in our "Terpene Operations"segment. The product continues to have strong demand from pious uses; although statesannounced lockdowns and temples were closed people at large continued to pray at home andused Camphor for aarti through the Delta and Omicron waves of COVID-19. In fact suchstrong is peoples belief in camphor that people diffused Bhimseni Camphor to help keepthem calm and relaxed through such difficult times of COVID-19. Other products in 'TerpeneOperations" such as Dipentene and Sodium Acetate also fetch us good value now withthe expansion completed we look forward to other terpene intermediates also contributingto our growth.
On the "Synthetic Resins" front a slight recovery wasvisible as other manufacturing units were able to work on an uninterrupted basis. OurSynthetic Resin strategy is in place there is stable demand and healthy margins in theproducts we manufacture. With increasing prices of petrochemical-based resins and ageneral move towards greener materials we are noticing favourable scenarios ahead in thedomestic and international market for our range of resins.
Our "Retail Operations" consist of three elements sales from"Mangalam" "CamPure" and private label initiatives. We have seenrobust growth in all three elements. Our brands are experiencing volume growth from ourexpansions in General Trade across India
Increasing number of Modern Trade stores increasing penetration ofE-commerce and exploring new channels such as institutional and corporate gifting avenues.To support the growing demand we have also augmented our retail products manufacturingfacilities by
investing in state of the art machines and are now well positioned tocater to increased requirements with less chance of stock out situations at peak times. Onthe branding front we continue to invest money astutely through innovative campaignsacross TV Digital and exhibitions accompanied with lots of sampling to drive productawareness and trials.
Once again on behalf of the Management and Board of Directors wewould like to take this opportunity to thank all our stakeholders our shareholdersemployees suppliers and various government departments for their unwavering support andtrust. We are glad to have your continued support and we will endeavour to meet yourexpectations.
Executive Director and Chairman
Executive Director and Managing Director